Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospective study
Author:
Funder
Chang Gung Memorial Hospital, Taiwan
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference24 articles.
1. Extended-spectrum β-lactamases: a clinical update;Paterson;Clin Microbiol Rev,2005
2. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern;Pitout;Lancet Infect Dis,2008
3. Extended-spectrum β-lactamases and clinical outcomes: current data;Ramphal;Clin Infect Dis,2006
4. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study;Falagas;J Antimicrob Chemother,2007
5. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates;Lee;J Antimicrob Chemother,2006
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fourth national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from patients with complicated urinary tract infections;Journal of Infection and Chemotherapy;2024-07
2. Cefoxitin versus carbapenems as definitive treatment for extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteremia in intensive care unit: a propensity-matched retrospective analysis;Critical Care;2023-11-01
3. Efficacy and Safety of Cefmetazole for Bacteremia Caused by Extended-Spectrum β-Lactamase–Producing Enterobacterales vs Carbapenems: A Retrospective Study;Open Forum Infectious Diseases;2023-09-30
4. Cefoxitin versus carbapenems as definitive treatment for Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae bacteremia in intensive care unit: a propensity-matched retrospective analysis;2023-09-06
5. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections;Clinical Infectious Diseases;2023-07-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3